Back to Search
Start Over
Garcimultiflorone K from Garcinia multiflora attenuates hepatocellular carcinoma metastasis by suppressing transforming growth factor-β signaling.
- Source :
-
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2021 Apr; Vol. 84, pp. 153502. Date of Electronic Publication: 2021 Feb 12. - Publication Year :
- 2021
-
Abstract
- Background: Transforming growth factor‑β (TGF-β) signaling is a crucial inducer of tissue fibrosis and extracellular matrix accumulation and a vital suppressor of epithelial cell proliferation and cancer metastasis. The nature of this multifunctional cytokine has prompted the development of TGF-β signaling inhibitors as therapeutic agents. Our research group has recently isolated the polyprenylated polycyclic acylphloroglucinol garcimultiflorone K (GMK) from the stems of Garcinia multiflora; GMK exhibits antiangiogenic activity in endothelial cells.<br />Purpose: In the current study, we aimed to explore the antitumor effect and detailed mechanisms of Garcimultiflorone K in hepatocellular carcinoma cells.<br />Methods: Cell proliferation and viability were evaluated using the MTT assay. The migratory ability of HepG2 cells was measured using wound healing assays. The inhibitory effect of GMK against the nuclear translocation of Smad by TGF-β was assessed through immunofluorescence staining and Western blotting. To investigate TGF-β-dependent gene expression profiles upon GMK stimulation, RNA transcript levels were determined using reverse transcription polymerase chain reaction. The effects of GMK in Smad2-driven transcriptomic activities were studied using a reporter gene assay. Protein levels were detected using Western blotting.<br />Results: Our data revealed that GMK inhibited TGF-β-induced cellular responses, including Smad protein phosphorylation, cell migration, and extracellular matrix production, during epithelial-mesenchymal transition (EMT). Mechanistic studies further demonstrated that GMK suppressed TGF-β signaling by downregulating TGF-β receptor II (TβRII).<br />Conclusion: These findings elucidate that TβRII expression in hepatic cells can be specifically suppressed by GMK to attenuate metastasis and the disease-promoting effects of EMT, representing a therapeutic approach.<br /> (Copyright © 2021. Published by Elsevier GmbH.)
- Subjects :
- Animals
Antineoplastic Agents, Phytogenic pharmacology
Carcinoma, Hepatocellular pathology
Cell Line, Tumor
Cell Movement drug effects
Cell Proliferation drug effects
Epithelial-Mesenchymal Transition drug effects
Garcinia chemistry
Hep G2 Cells
Hepatic Stellate Cells drug effects
Hepatic Stellate Cells pathology
Humans
Liver Neoplasms pathology
Mice
Phosphorylation drug effects
Rats
Receptors, Transforming Growth Factor beta genetics
Signal Transduction drug effects
Carcinoma, Hepatocellular drug therapy
Liver Neoplasms drug therapy
Phloroglucinol pharmacology
Transforming Growth Factor beta metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1618-095X
- Volume :
- 84
- Database :
- MEDLINE
- Journal :
- Phytomedicine : international journal of phytotherapy and phytopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 33647775
- Full Text :
- https://doi.org/10.1016/j.phymed.2021.153502